Newsmeme!
Discover News you didn't know existed
Heather Mills' ex-publicist has accused the former model of a campaign of dirty tricks against Paul McCartney during their bitter divorce row.
Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety endpoints in patients with multi-vessel disease and diabetes.
Digirad Corporation (Nasdaq: DRAD), a leading provider of medical diagnostic imaging systems and services to physicians' offices, hospitals and imaging centers, announced the initial clinical trial of a new imaging system incorporating new proprietary technology to correct attenuation, or image distortion, an inherent issue in cardiac SPECT imaging.
Medical products makers thrive on innovation.
Players try to keep their pipelines flowing with new and improved products so they can meet doctors' and patients' ever-changing needs.
Cigna Healthcare, a subsidiary of Cigna Corp., announced this week that Tenet Healthcare Corp. has received 214 Cigna Healthcare quality designations based on the outcomes of 29 surgical procedures and medical conditions at 38 hospitals.
The Medicines Company (NASDAQ: MDCO) announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.
The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI).
Digirad Corporation , a leading provider of medical diagnostic imaging systems and services to physicians' offices, hospitals and imaging centers, today announced the initial clinical trial of a new imaging system incorporating new proprietary technology to correct attenuation, or image distortion, an inherent issue in cardiac SPECT imaging.
MUNICH----Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery in key safety endpoints in patients with multi-vessel disease and diabetes.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |